Differences in transcription in Angelman syndrome and control person iPSC-derived neurons
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA611562 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR11271979_1.fastq.gz | Fastqsanger.gz | |||
| SRR11271979_2.fastq.gz | Fastqsanger.gz | |||
| SRR11271980_1.fastq.gz | Fastqsanger.gz | |||
| SRR11271980_2.fastq.gz | Fastqsanger.gz | |||
| SRR11271981_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 28 |
Similar Datasets
Project description:Angelman syndrome is caused by loss of funtional ubiquitin E3 ligase UBE3A and results in severe deley in cognitive and motor development. In neurons, UBE3A locates to the synapse and to the nucleus. Loss of nuclear UBE3A results in development of Angelman syndrome like symptoms in mice. UBE3A can function as transcriptional coactivator of steroid hormone receptors, but the entire function of UBE3A in the nucleus is still not clear. So we wanted to study differences in the transcriptome in neurons differentiated from iPSCs that were derived from patients with Angleman syndrome and normal controls.
2020-12-31 | GSE146640 | GEO
Project description:mRNAseq on (1) isogenic control and Angelman Syndrome pluripotent stem cell-derived neurons or (2) antisense oligonucleotide-treated H9 hESC-derived neurons
2021-04-01 | GSE160747 | GEO
Project description:Angelman syndrome is a severe neurodevelopmental disorder caused by loss of UBE3A, a gene that encodes an E3 ubiquitin ligase. The mechanisms underlying this disorder are not well understood, and the link between UBE3A substrates and disease phenotypes remains uncertain. Here, we identify asparagine synthetase (ASNS) as a novel target of UBE3A. We find that ASNS protein levels are elevated in brains of Angelman syndrome model mice, and metabolomic analysis revealed these animals possess imbalanced amino acid levels leading to a persistent activation of the integrated stress responseincrease in stress signaling and a global reduction in neuronal protein synthesis. When ASNS levels were genetically reduced in mutant animals, stress signaling and protein synthesis rates were corrected, and many behavioral and neuroanatomical deficits were rescued. Our results suggest that UBE3A operates in neurons to clear stress signaling, and our resultsfurther suggest that ASNS and the integratedthe stress response are potential therapeutic targets in Angelman syndrome.
2026-09-02 | GSE319851 | GEO
Project description:Angelman syndrome is a neurodevelopmental disorder caused by the loss of the maternal allele of the ubiquitin-protein ligase E3A (UBE3A) gene. UBE3A is imprinted with maternal-allelic expression in neurons of the central nervous syndrome (CNS) and biallelically expressed in other cell types. Consequently, in Angelman syndrome, UBE3A is absent in CNS neurons and reduced by half in other cells. It is unclear how cell type-specific gene expression in the brain is dysregulated in Angelman syndrome. Using single nuclei RNA-sequencing, we show that gene expression is dysregulated in neuronal subtypes in the frontal cortex of neonatal pigs with a UBE3A maternal deletion. A total of 3,812 unique genes were dysregulated across ten cell-type clusters, with most of the dysregulated genes (3,154 genes) in excitatory neurons.
2025-12-23 | GSE314025 | GEO
Project description:Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of function of the maternal allele of the neuron-specific imprinted gene UBE3A. Although AS presents with developmental delay, ataxia, epilepsy, and speech impairment, the distinct roles of various brain regions in its pathology remain unclear, hindering the design of effective therapeutic strategies. Of all brain regions, the nature and impact of dysfunction of the cerebellum in AS remain elusive. To start addressing this, we leveraged our optimized stem cell-based model of regionally patterned human cerebellar organoids (hCerOs) capable of producing major cerebellar neuronal subtypes, including Purkinje and granule cells, further matured in a two-dimensional (2D) culture system. We modeled AS using induced pluripotent stem cell (iPSC) lines carrying the common class II deletion and unaffected controls previously validated in our system. hCerOs from both backgrounds recapitulate lineage commitment and neuron-specific UBE3A imprinting. AS hCerOs consistently show reduced size, impaired neuroepithelial expansion, and diminished expression of glutamatergic and GABAergic progenitor markers. Transcriptomic profiling and functional assays assessing neuronal activity during the maturation stage uncovered delayed maturation, abnormal firing and increased neuronal excitability in AS cultures. These results position our hCerO model as a robust platform for future mechanistic studies and therapeutic screening aimed at targeting cerebellar dysfunction in AS.
2026-09-15 | GSE307429 | GEO
Project description:Angelman syndrome (AS) is a neurogenetic developmental disorder that results from the loss of E3 ubiquitin ligase UBE3A due to mutations in or deletions of the maternally inherited UBE3A allele. While mouse models of AS have implicated abnormal synaptic signaling and plasticity underlying behavioral dysfunction, how the loss of UBE3A contributes to hyperactivity of neuronal networks seen in AS patients remains unclear. Here, by utilizing human induced neurons and 3D cortical organoids derived from AS patient iPSCs and CRISPR-Cas9 mediated UBE3A KO hESCs, we uncovered a novel role of UBE3A in suppressing neuronal hyperexcitability via ubiquitin-mediated degradation of BK channels. More importantly, augmented BK channel activity in neurons manifested as increased intrinsic excitability of neurons and network level bursting and synchronization, which can be pharmacologically normalized by BK antagonists. Our study has illustrated the utility of modeling neurological diseases with human neural cells, and our results have provided new insights into underlying pathophysiological mechanisms and potential therapeutic strategy in Angelman syndrome.
2020-08-18 | GSE120225 | GEO
Project description:Establishing a molecular phenotype for Angelman Syndrome stem cell-derived neurons
| PRJNA674346 | ENA
Project description:Persistent neuronal stress signaling underlies Angelman syndrome phenotypes
| PRJNA1425309 | ENA
Project description:Angelman syndrome (AS) and interstitial duplication 15q autism (int dup(15)) are reciprocal genomic disorders caused by maternal deletion or duplication of the 15q11.2-q13 region. While AS is caused by maternal loss of 15q and maternal duplications of 15q can cause autism implicating the maternally expressed UBE3A gene in these phenotypes. We investigated chromatin and gene expression changes in blood and cell lines from three int dup(15) and three reciprocal AS deletion subjects to identify global genomic and gene expression changes that may influence both the AS and autism phenotypes. Using formaldehyde-assisted isolation of regulatory elements (FAIRE) we identified 1104 regions of differential open chromatin in AS deletion and 2344 regions int dup(15) indicating changes in chromatin could influence gene expression in these regions. Microarray analysis revealed 1225 genes that were elevated in AS deletion vs int dup(15) and 976 genes that were elevated in int dup(15) vs AS deletion PBMC (pvalue<0.05). Significant differences in expression were found for genes at the 15q locus like UBE3A, ATP10A and HERC2. A larger set of genes involved in chromatin remodeling, DNA repair and neurogenesis were found, at FAIRE peaks in AS deletion samples but had increased transcription in int dup(15) samples. There was a significant enhancement for genes with FOXP1 binding sites in the int dup(15) gene set and elevated FOXP1 protein could be detected in the nucleus of int dup(15) as compared to AS deletion cell lines. This analysis provides the first insights into transcriptional changes which may unveil new sets of genes and pathways contributing to both AS and autism pathogenesis. Gene expression was performed using 100ng of total RNA from each subject as starting material for amplification and cRNA synthesis in accordance Affymetrix protocols (http://tinyurl.com/3j7dcp6). Hybridizations were performed to the Affy HumanGene_st_v1 chip and the signal data normalized using internal chip controls. Normalized expression data was then exported to a text file for subsequent expression analysis using the EXPANDER software analysis suite.
2014-10-09 | E-GEOD-32563 | biostudies-arrayexpress